Clinical Trial Update: Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism [NA]

View source ↗

Summary

This update reports the completion of a dose-ranging clinical trial of recombinant human insulin-like growth factor I in children with hyperinsulinism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinism

Drugs mentioned

• Recombinant human insulin-like growth factor I (insulin-like growth factor I)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Hyperinsulinism | NA | Status: COMPLETED